These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20876433)

  • 1. Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: a prospective study.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Sachanandani H; Ellenbogen KA
    Circulation; 2010 Oct; 122(15):1449-55. PubMed ID: 20876433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Stadler RW; Gillberg JM; Patel AS; Ellenbogen KA
    Circulation; 2008 Nov; 118(21):2122-9. PubMed ID: 18981299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures.
    Kallinen LM; Hauser RG; Tang C; Melby DP; Almquist AK; Katsiyiannis WT; Gornick CC
    Heart Rhythm; 2010 Aug; 7(8):1048-55. PubMed ID: 20493965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An algorithm to predict implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Patel AS; Bounds CA; Shepard RK; Wood MA; Ellenbogen KA
    J Am Coll Cardiol; 2004 Nov; 44(9):1898-902. PubMed ID: 15519026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of inappropriate ICD shocks due to lead insulation failure by continuous monitoring and automatic alert.
    Gelder RN; Gunderson BD
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):e150-3. PubMed ID: 22309317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads.
    Ellenbogen KA; Gunderson BD; Stromberg KD; Swerdlow CD
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1169-77. PubMed ID: 24099976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inappropriate shocks in patients with Fidelis® lead fractures: impact of remote monitoring and the lead integrity algorithm.
    Blanck Z; Axtell K; Brodhagen K; O'Hearn L; Albelo T; Ceretto C; Dhala A; Sra J; Akhtar M
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1107-14. PubMed ID: 21539638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy, and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: the PainFree SST clinical study design.
    Auricchio A; Meijer A; Kurita T; Schloss E; Brinkman K; Claessens-van Ooijen M; Sterns L
    Europace; 2011 Oct; 13(10):1484-93. PubMed ID: 21669960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automatic R-wave and impedance testing with the modern patient alert system to reduce inappropriate implantable cardioverter defibrillator shocks due to lead fracture.
    Chinushi M; Hosaka Y; Ikarashi N; Iijima K; Furushima H; Aizawa Y
    Europace; 2008 Jun; 10(6):738-40. PubMed ID: 18390874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate implantable cardioverter-defibrillator discharges unrelated to supraventricular tachyarrhythmias.
    Occhetta E; Bortnik M; Magnani A; Francalacci G; Marino P
    Europace; 2006 Oct; 8(10):863-9. PubMed ID: 16916859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient alert in implantable cardioverter defibrillators: toy or tool?
    Becker R; Ruf-Richter J; Senges-Becker JC; Bauer A; Weretka S; Voss F; Katus HA; Schoels W
    J Am Coll Cardiol; 2004 Jul; 44(1):95-8. PubMed ID: 15234415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defribrillator shocks: a troubleshooting guide.
    Swerdlow CD; Zhang J
    Rev Cardiovasc Med; 2001; 2(2):61-72. PubMed ID: 12439383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead Integrity Alert Is Useful for Assessment of Performance of Biotronik Linox Leads.
    Steinberg C; Padfield GJ; Hahn E; Flavelle S; McILROY C; VAN Bremen O; Yeung-Lai-Wah JA; Kerr CR; Deyell MW; Tung SK; Andrade JG; Bennett MT; Bashir JG; Krahn AD; Chakrabarti S
    J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1340-5. PubMed ID: 26471861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies].
    Weber M; Block M; Brunn J; Bänsch D; Böcker D; Hammel D; Gietzen F; Breithardt G
    Z Kardiol; 1996 Nov; 85(11):809-19. PubMed ID: 9064943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.